Additionally, Ma et al., demonstrated that SP1 has the ability to reverse the impact of repressor element-1 silencing transcription factor (REST) on erastin-induced LUHMES cell viability, ROS production, ferroptosis, and neuronal damage, implying that REST may alleviate PD by reducing SP1 activity [118]. This evidence concerns the gene REST and Parkinson disease.